Related Experiment Video

Updated: Mar 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K

Oral Anticoagulation in the Elderly: New Oral Anticoagulants-Innovative Solution for an Old Problem?

Mario Barbosa1, Luiz Menezes Falcão2

  • 1Emergency Department, Vila Franca de Xira Hospital and Internal Medicine Department of the CUF Torres Vedras Hospital, Torres Vedras, Portugal.

American Journal of Therapeutics
|August 31, 2016
PubMed

Insights

Direct oral anticoagulants (DOACs) show promise for cardiovascular disease prevention. This review focuses on their benefits and risks, particularly for elderly patients, addressing remaining clinical uncertainties.

Area of Science:

  • Cardiology
  • Pharmacology
  • Geriatrics

Background:

  • Direct oral anticoagulants (DOACs) are increasingly used for cardiovascular disease prevention and treatment.
  • Despite extensive research, clinical uncertainties persist regarding DOAC use in specific patient populations.
  • These include patients with prosthetic valves, valvular atrial fibrillation, the elderly, and those with paraneoplastic thromboembolism or severe pulmonary embolism.

Purpose of the Study:

  • To review and synthesize current scientific literature on DOACs.
  • To focus on the advantages and disadvantages of DOACs specifically in elderly patients.
  • To address remaining uncertainties in DOAC application.

Main Methods:

  • Literature review of studies and meta-analyses on DOACs.
  • Synthesis of data concerning DOAC efficacy and safety.
  • Focus on evidence pertaining to geriatric populations.

Main Results:

  • DOACs offer significant advantages in cardiovascular disease management.
  • Uncertainties remain regarding optimal DOAC use in specific groups, including the elderly.
  • Limited availability of specific antidotes for DOACs is a concern.

Conclusions:

  • DOACs represent a significant advancement in anticoagulation therapy.
  • Further research is needed to clarify DOAC use in vulnerable populations, especially the elderly.
  • Addressing DOAC-specific challenges, such as antidote availability, is crucial for safe and effective clinical practice.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.5K

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
453
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
340
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
308
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
788